Navigation Links
MedCath Names Parker to New Finance Post
Date:5/12/2008

CHARLOTTE, N.C., May 12 /PRNewswire-FirstCall/ -- MedCath Corporation (Nasdaq: MDTH), a health care provider focused on high acuity health care services, predominantly the diagnosis and treatment of cardiovascular disease, today announced that Art Parker, Senior Vice-President and Treasurer and currently Interim Chief Financial Officer, has been named Senior Vice-President, Finance and Development effective immediately.

"In his new role, Art will continue to oversee and direct Treasury and other Finance activities but will also be engaged in the acquisition and transactional pipeline, due diligence and other development matters," according to O. Edwin French, MedCath's President and Chief Executive Officer. "Art has distinguished himself as a capable and engaged executive who has earned the confidence of our partners and bankers, and who has proven himself in several transactions during his time with MedCath. We are developing our bench strength to match our growth ambitions, and Art will be important to that process."

Prior to joining MedCath in 2001, Parker worked for Bank of America for 14 years, holding posts related to the management of commercial banking relationships, the development of credit underwriting standards and approvals, and serving as a fixed income bond analyst covering the health care and other industries.

He holds a bachelor's degree in business administration from the University of Georgia and an MBA from Wake Forest University, Winston-Salem, N.C.

MedCath is nearing a completion of its search for a chief financial officer to fill the post vacated in January. An announcement is expected within the next several weeks.

MedCath Corporation, headquartered in Charlotte, N.C., is a health
'/>"/>

SOURCE MedCath Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. MedCath Corporation to Present at the Banc of America Securities 2008 Health Care Conference
2. MedCath Corporation Reports Second Quarter Earnings
3. MedCath Corporation to Present at the Deutsche Bank Securities 33rd Annual Health Care Conference
4. MedCath Provides Preliminary Second Quarter Fiscal 2008 Earnings and Updates Fiscal 2008 Outlook
5. Woodrin Woody Grossman Appointed to MedCaths Board of Directors
6. Pamela G. Bailey and Edward R. Casas, M.D. Appointed to MedCaths Board of Directors
7. MedCath Announces Acquisition of Ownership in Arizona Cath Lab
8. MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital-Dayton
9. MedCath Corporation to Present at the Citi 2008 Small and Mid-Cap Conference
10. MedCath Corporation to Present at the Raymond James 29th Annual Institutional Investors Conference
11. MedCath Announces Venture With Two New Jersey Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... NEW JERSEY, Oct. 6 /PRNewswire/ -- The organizer...gural conference on Global Sourcing for the,Pharma... 2008 at the,Princeton Marriott in New Jersey USA....sident & CEO of the,Global Sourcing Council, and b...rs including the likes of Johnson & Johnson, Brist...
(Date:10/6/2008)... LegalView recently posted ...tal regarding the potentially serious side effects...hibitors. Among the drug,s potential side effects ...-causing agents for young adult and child patients...tober 6, 2008 -- LegalView, the number one resourc...
(Date:10/6/2008)... Hospital Ship Serving in W... Garden Valley, Texas October 6, 200...e premier global provider of communications servic...s donated access to the FoxNews channel via satell...agship, the Africa Mercy. The Africa Mercy is the...
(Date:10/6/2008)... WALLDORF, Germany, Oct. 6 /PRNewswire-FirstCall/... Papandrea has joined SAP as senior vice president... position, effective,August 1, 2008, Mr. Papandrea... in providing strategic software solutions to heal...ement was made in conjunction,with the 3rd annual ...
Breaking Medicine News(10 mins):Health News:Global Sourcing Strategies for the Pharmaceutical Industry 10th - 11th November, Marriott Princeton, New Jersey USA 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 2Health News:LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis 3Health News:Seamobile Provides Foxnews To Mercy Ships 2Health News:Seamobile Provides Foxnews To Mercy Ships 3Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 2Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 3
...s women who allow only short intervals of time bet...loping complications. Researchers in Scotland stud...between 1992 and 1998. Results of the study show w...ch more likely to become pregnant again in less th...
...mmonly used to lower cholesterol levels appear to ... unknown cause. The disease, known as idiopathic d...d heart that doesn't pump properly. Unlike the mos... due to a blockage of the coronary arteries that f...
... the majority of the public still does not know ch...e lives, the American Heart Association believes t...s. Their new study finds physicians, overall, need... disease is the leading cause of death in the Unit...
...eering fertility treatment 25 years ago, IVF has n...s born in the United States alone, according to th...is a procedure that involves retrieving the eggs f...th sperm from the father. The resulting embryo is ...
Other Medicine News:Health News:Test tube babies, 25 years later 2
(Date:10/6/2008)... - Data Presented at ACG Annual Scientific C...- Ironwood Pharmaceuticals,(formerly Microbia) tod...reclinical studies delineating the role that cycli...ing intestinal pain. These studies,demonstrate tha...odel of,intestinal hyperalgesia and desensitizes c...
(Date:10/6/2008)... Results from Phase 3b Studies with Durezol Dosed .../ -- Sirion Therapeutics, Inc., a,privately held o...nced,today that Durezol(TM) (difluprednate ophthal... Durezol, which was approved by the U.S. Food and,...thalmic corticosteroid,indicated for the treatment...
(Date:10/6/2008)...More than 60 percent of moderate to severe patient...rcent achieved endoscopic remission at Week 10,in ...the American College,of Gastroenterology (ACG) Ann...Newswire/ -- UCB today presented data from a,large...vement in Crohn,s,disease (CD) with a biologic com...
(Date:10/6/2008)...SEATTLE, Oct. 6 /- Dendreon... call today, Monday, October 6, 2008 at 9:00 AM,ET... analysis of its IMPACT,(IMmunotherapy for Prostat...clinical trial of PROVENGE(R) (sipuleucel-T), the ...erapy for the treatment of advanced prostate,cance...
Breaking Medicine Technology:Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2TGen and Washington University researchers discover new approach to treating endometrial cancer 4660 1TGen and Washington University researchers discover new approach to treating endometrial cancer 4660 2TGen and Washington University researchers discover new approach to treating endometrial cancer 4660 3ICERx org Activated to Provide Emergency Access to Prescription Medication Information for Hurricane Gustav Evacuees 25915 1American Red Cross Relief Efforts Underway for Gustav 25910 1American Red Cross Relief Efforts Underway for Gustav 25910 2New master switch found in the brain that regulates appetite and reproduction 4655 1New master switch found in the brain that regulates appetite and reproduction 4655 2New master switch found in the brain that regulates appetite and reproduction 4655 3New master switch found in the brain that regulates appetite and reproduction 4655 4
...ire-FirstCall/ - Bradmer,Pharmaceuticals Inc., a b...ent and commercialization of cancer therapies, tod...ependent team in,Basel, Switzerland validates tena...lopment of new treatments for glioblastoma,multifo...oss of NOTCH2 gene,positively predicts survival in...
...2007 - AVI BioPharma, Inc.,(Nasdaq:AVII) announced... target patient enrollment and released six-month,...n as Appraisal.,The trial, currently being held in...Neugene(R) antisense drug Resten-MP(TM), when,used...bare metal,stents, in the prevention of cardiovasc...
Other Medicine Technology:Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 2Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 3Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 4AVI BioPharma Partner Cook Medical Announces Completion of Patient,Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of,Cardiovascular Disease 2
Straight heavy shafts with delicate 7 mm tying platform. Sharp pointed tips for removing fine sutures. Wide serrated handle with polished finish. Overall length 4.1 inches.
Tying forceps with 6.5 mm tying platform. Round handle with flats provide flexibility of round handle with the stability of a flat handle. Curved shafts. Overall length 3.9 inches.
Delicate curved tying forcep with round handle is excellent for all fine suturing techniques. Useful for corneal transplants where delicate control is required.
Straight, 7 mm tying platform. Castroviejo handle. Manufactured in titanium. Overall length 4.2 inches.
Medicine Products: